oral ulcer. Other oral mucositis (ulcerative)
Conditions
Interventions
Intervention 1: Intervention group: in main intervention group the patients will use this formulated mouthwash (chitosan, doxepin) made in Shiraz Pharmacy University as an analgesic agent. The partici
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
12 Years to No maximum
Inclusion criteria
Inclusion criteria: The patient who has painful new oral lesion without receiving any treatment The patients who are not pregnant The patients who are not diabetic The patients with no other inflammatory diseases The patients who sign the written consent form
Exclusion criteria
Exclusion criteria: The patients who have used any analgesic agents (systemic or local) since 2 days ago The patients who have used any anti-inflammatory medication such as corticosteroid since 2 weeks ago
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Level of pain. Timepoint: after gargling these analgesics agent for 5 minute, VAS of patients will be measured in 5, 15, 30 and 1 hour intervals. Their VAS will be measured after each gargling also in day 1,2,3. Method of measurement: visual analogue scale.;The size of oral ulcer. Timepoint: The size of oral lesions will be measured after gargling in day 1,2,3 in intervention and control groups. Method of measurement: scaled tongue blade. | — |
Secondary
| Measure | Time frame |
|---|---|
| The side effects of using mouth washes. Timepoint: day 1,2,3 and a week after using mouth wash. Method of measurement: asking the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Lavaee
Shiraz University of Medical Sciences
Outcome results
None listed